Welcome to 3D Biotek - See the Difference 3D Can Make!
3D Biotek, LLC is a high-tech biomedical engineering company located in New
Jersey, USA. Using its Precision 3D Micro-Fabrication Technology and Advanced
Bio-Manufacturing Technology, 3D Biotek is a leader and the industry's only
dedicated driving force in the research and development of novel 3-dimensional
(3D) cell culture devices for stem cell/tissue engineering, drug discovery and
broad cell biology applications. 3D Biotek provides the finest quality 3D cell
culture products and produces customized products to fit our clients’ special
needs.
Introducing 3D Cell Expansion System (3D-CES)
3D-CES is a novel integrated system designed for large-scale expansion of
anchorage-dependent cells in a 3D micro-environment. Adipose-Derived Stem Cells
(ASCs) and Primary Human Fibroblasts (hFbs) were successfully expanded in 3D
Biotek's laboratory to 200-300 million in about 2 weeks or less. The 2-chamber
design of the system allows a max capacity of about 500 million cells per
production run. The fully automatic system will be launched to the market on Q3-2024. Click
here for detail.
"Standards and Measurements for Tissue Engineering Scaffolds: What Do We
Have; What Do We Need?"
To read related newsletter (May 2013 Issue 1), click
here for more detail.
Cell culture goes 3-D with devices that better mimic in vivo conditions.
Featured article on The Scientist, September 1, 2012. Click
here for more detail.
"A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of
Lymphoma Cancer Cells from Heterogeneous Cell Mixtures." Click
here to read the recent research article published on Journal of Tissue
Engineering by 3D Biotek and the Cancer Center of Hackensack University.
3D Biotek Seeks to Mimic In Vivo Cell Growth & Behavior Characteristics With
Its Technology. Click
here to read the featured article on GEN (Genetic Engineering &
Biotechnology News).
Powerful and versatile tool beginning to demonstrate significant potential.
Click
here to read the featured article on GEN (Genetic Engineering &
Biotechnology News).
|